Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc.verified

HTSUF

Price:

$29

Market Cap:

$302.08B

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HA...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2010-09-23

Stock Exchange

OTC

Ticker

HTSUF

The PE Ratio as of December 2025 (TTM) for Hisamitsu Pharmaceutical Co., Inc. (HTSUF) is 16.76

According to Hisamitsu Pharmaceutical Co., Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 16.76. This represents a change of -8.18% compared to the average of 18.25 of the last 4 quarters.

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Historical PE Ratio (quarterly & annually)

How has HTSUF PE Ratio performed in the past?

The mean historical PE Ratio of Hisamitsu Pharmaceutical Co., Inc. over the last ten years is 27.94. The current 16.76 PE Ratio has changed 5.90% with respect to the historical average. Over the past ten years (40 quarters), HTSUF's PE Ratio was at its highest in in the May 2020 quarter at 975.66. The PE Ratio was at its lowest in in the February 2025 quarter at 9.53.

Quarterly (TTM)
Annual

Average

27.94

Median

24.47

Minimum

14.29

Maximum

59.27

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Hisamitsu Pharmaceutical Co., Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 178.98%

Maximum Annual PE Ratio = 59.27

Minimum Annual Increase = -48.07%

Minimum Annual PE Ratio = 14.29

Quarterly (TTM)
Annual
YearPE RatioChange
202514.29-33.76%
202421.57-16.42%
202325.81-16.13%
202230.78-48.07%
202159.27178.98%
202021.25-11.13%
201923.91-29.42%
201833.8735.30%
201725.036.14%
201623.5915.82%

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Average PE Ratio

How has HTSUF PE Ratio performed in the past?

The current PE Ratio of Hisamitsu Pharmaceutical Co., Inc. (HTSUF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

20.56

5-year avg

30.34

10-year avg

27.94

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) PE Ratio vs. Peers

How is HTSUF’s PE Ratio compared to its peers?

Hisamitsu Pharmaceutical Co., Inc.’s PE Ratio is less than Dermapharm Holding SE (19.20), greater than Tsumura & Co. (11.21), less than China Medical System Holdings Limited (17.91), greater than Sihuan Pharmaceutical Holdings Group Ltd. (-138.39), greater than Curaleaf Holdings, Inc. (-8.25), less than Fagron N.V. (17.88), less than Almirall, S.A. (129.63), greater than CanSino Biologics Inc. (-115.09), greater than HUTCHMED (China) Limited (5.30), less than BioArctic AB (publ) (28.04),

Build a custom stock screener for Hisamitsu Pharmaceutical Co., Inc. (HTSUF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hisamitsu Pharmaceutical Co., Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hisamitsu Pharmaceutical Co., Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Hisamitsu Pharmaceutical Co., Inc.'s PE Ratio?

How is the PE Ratio calculated for Hisamitsu Pharmaceutical Co., Inc. (HTSUF)?

What is the highest PE Ratio for Hisamitsu Pharmaceutical Co., Inc. (HTSUF)?

What is the 3-year average PE Ratio for Hisamitsu Pharmaceutical Co., Inc. (HTSUF)?

What is the 5-year average PE Ratio for Hisamitsu Pharmaceutical Co., Inc. (HTSUF)?

How does the current PE Ratio for Hisamitsu Pharmaceutical Co., Inc. (HTSUF) compare to its historical average?